Your browser doesn't support javascript.
Immunoinformatics approaches to explore B and T cell epitope-based vaccine designing for SARS-CoV-2 virus
Pakistan Journal of Pharmaceutical Sciences ; 34(1 Suppl):345-352, 2021.
Article in English | GIM | ID: covidwho-1478998
ABSTRACT
SARS-CoV-2, a new world coronavirus belonging to class Nidovirales of Coronaviridae family causes COVID-19 infection which is the leading cause of death worldwide. Currently there are no approved drugs and vaccines available for the prevention of COVID-19 infection, although couples of immunizations are being tested in clinical trials. However, the present efforts are focused on computational vaccination technique for evaluating candidates to design multi-epitope-based vaccine against pathogenic mechanism of novel SARS-COV-2. Based on recent published evidence, we recognized spike glycoprotein and envelope small membrane protein are the potential targets to combat the pathogenic mechanism of SARS-CoV-2. Similarly, in the present study we identified epitope of both B and T cell associated with these proteins. Extremely antigenic, conserve, immunogenic and nontoxic epitope of B and T cell of Spike protein are WPWYVWLGFI, SRVKNLNSSEGVPDLLV whereas the CWCARPTCIK and YCCNIVNVSL are associated with envelope small membrane protein were selected as potential candidate for vaccine designing. These epitopes show virtuous interaction with HLAA0201 during molecular docking analysis. Under simulation protocol the predicted vaccine candidates show stability. Collectively, this work provides novel potential candidates for epitope-based vaccine designing against COVID-19 infection.

Full text: Available Collection: Databases of international organizations Database: GIM Type of study: Clinical Practice Guide Topics: Vaccines Language: English Journal: Pakistan Journal of Pharmaceutical Sciences Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: GIM Type of study: Clinical Practice Guide Topics: Vaccines Language: English Journal: Pakistan Journal of Pharmaceutical Sciences Year: 2021 Document Type: Article